1. Home
  2. VRCA vs ALAR Comparison

VRCA vs ALAR Comparison

Compare VRCA & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRCA
  • ALAR
  • Stock Information
  • Founded
  • VRCA 2013
  • ALAR 2013
  • Country
  • VRCA United States
  • ALAR Israel
  • Employees
  • VRCA N/A
  • ALAR N/A
  • Industry
  • VRCA Biotechnology: Pharmaceutical Preparations
  • ALAR Computer Software: Prepackaged Software
  • Sector
  • VRCA Health Care
  • ALAR Technology
  • Exchange
  • VRCA Nasdaq
  • ALAR Nasdaq
  • Market Cap
  • VRCA 43.0M
  • ALAR 45.3M
  • IPO Year
  • VRCA 2018
  • ALAR 2018
  • Fundamental
  • Price
  • VRCA $0.54
  • ALAR $6.75
  • Analyst Decision
  • VRCA Hold
  • ALAR Strong Buy
  • Analyst Count
  • VRCA 5
  • ALAR 1
  • Target Price
  • VRCA $6.00
  • ALAR $11.00
  • AVG Volume (30 Days)
  • VRCA 263.8K
  • ALAR 130.2K
  • Earning Date
  • VRCA 05-13-2025
  • ALAR 05-29-2025
  • Dividend Yield
  • VRCA N/A
  • ALAR N/A
  • EPS Growth
  • VRCA N/A
  • ALAR N/A
  • EPS
  • VRCA N/A
  • ALAR 0.07
  • Revenue
  • VRCA $7,179,000.00
  • ALAR $30,581,000.00
  • Revenue This Year
  • VRCA $127.85
  • ALAR N/A
  • Revenue Next Year
  • VRCA $105.09
  • ALAR $12.28
  • P/E Ratio
  • VRCA N/A
  • ALAR $11.37
  • Revenue Growth
  • VRCA N/A
  • ALAR 4.67
  • 52 Week Low
  • VRCA $0.38
  • ALAR $5.45
  • 52 Week High
  • VRCA $9.36
  • ALAR $46.69
  • Technical
  • Relative Strength Index (RSI)
  • VRCA 43.40
  • ALAR 41.81
  • Support Level
  • VRCA $0.49
  • ALAR $6.56
  • Resistance Level
  • VRCA $0.73
  • ALAR $8.57
  • Average True Range (ATR)
  • VRCA 0.07
  • ALAR 0.61
  • MACD
  • VRCA -0.01
  • ALAR -0.12
  • Stochastic Oscillator
  • VRCA 10.77
  • ALAR 10.82

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.

Share on Social Networks: